DOJ lauds Guardant Health’s cooperation in cancer test false claims case

DOJ

California-based cancer testing company Guardant Health agreed to pay more than $945,000 to settle allegations levied by the Department of Justice (DOJ) of violating the False Claims Act and Stark Law.

Guardant will pay nearly $914,000 to settle allegations of the violating the False Claims Act, including more than $600,000 in restitution, according to the company’s settlement agreement. Additionally, the company will pay more than $31,000 in an administrative settlement with the Defense Health Agency, the DOJ announced in a press release Tuesday.

The DOJ acknowledged the company’s voluntary self-disclosure to the Department of Health and Human Services’ Office of the Inspector General, among other remedial measures promptly undertaken in reaching settlement.

THIS IS MEMBERS-ONLY CONTENT

SINGLE MEMBERSHIP                                             CORPORATE MEMBERSHIP

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.